The internal state of medium spiny neurons varies in response to different input signals

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Qi, Zhen ^a,b   Miller, Gary W ^a,c   Voit, Eberhard O ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPROTEIN DARPP 32;

ACTION POTENTIAL; ANIMAL; ARTICLE; BASAL GANGLION; BIOLOGICAL MODEL; COMPUTER SIMULATION; FEMALE; HUMAN; MALE; METABOLISM; NERVE CELL; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; BASAL GANGLIA; COMPUTER SIMULATION; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; HUMANS; MALE; MODELS, NEUROLOGICAL; NEURONS; SYNAPTIC TRANSMISSION;

EID: 77951170019     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-26     Document Type: Article

References (57)

1. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990, 13:244-254. 10.1016/0166-2236(90)90104-I, 1695398.
2. Walaas SI, Aswad DW, Greengard P. A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 1983, 301:69-71. 10.1038/301069a0, 6296685.
3. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 2004, 44:269-296. 10.1146/annurev.pharmtox.44.101802.121415, 14744247.
4. Greengard P, Allen PB, Nairn AC. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 1999, 23:435-447. 10.1016/S0896-6273(00)80798-9, 10433257.
5. Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 1998, 281:838-842. 10.1126/science.281.5378.838, 9694658.
6. Fienberg AA, Greengard P. The DARPP-32 knockout mouse. Brain Res Brain Res Rev 2000, 31:313-319. 10.1016/S0165-0173(99)00047-8, 10719158.
7. Spencer HJ. Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester: evidence for glutamic acid as an excitatory transmitter in the rat striatum. Brain Res 1976, 102:91-101. 10.1016/0006-8993(76)90577-1, 1247881.
8. Girault JA, Spampinato U, Savaki HE, Glowinski J, Besson MJ. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--I. Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents. Neuroscience 1986, 19:1101-1108. 10.1016/0306-4522(86)90126-0, 3493448.
9. Nishi A, Kuroiwa M, Miller DB, O'Callaghan JP, Bateup HS, Shuto T, Sotogaku N, Fukuda T, Heintz N, Greengard P, Snyder GL. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci 2008, 28:10460-10471. 10.1523/JNEUROSCI.2518-08.2008, 2814340, 18923023.
10. Hemmings HC, Greengard P, Tung HY, Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 1984, 310:503-505. 10.1038/310503a0, 6087160.
11. Kesavapany S, Li BS, Amin N, Zheng YL, Grant P, Pant HC. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta 2004, 1697:143-153.
12. Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttila T. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Biochem Biophys Res Commun 2002, 298:693-698. 10.1016/S0006-291X(02)02543-3, 12419309.
13. Dhavan R, Greer PL, Morabito MA, Orlando LR, Tsai LH. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J Neurosci 2002, 22:7879-7891.
14. Nishi A, Snyder GL, Greengard P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 1997, 17:8147-8155.
15. Jin M, Bateup H, Padovan JC, Greengard P, Nairn AC, Chait BT. Quantitative analysis of protein phosphorylation in mouse brain by hypothesis-driven multistage mass spectrometry. Anal Chem 2005, 77:7845-7851. 10.1021/ac051519m, 16351129.
16. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999, 402:669-671. 10.1038/45251, 10604473.
17. Snyder GL, Galdi S, Fienberg AA, Allen P, Nairn AC, Greengard P. Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists. Neuropharmacology 2003, 45:703-713. 10.1016/S0028-3908(03)00319-8, 14529709.
18. Walaas SI, Greengard P. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J Neurosci 1984, 4:84-98.
19. Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, Greengard P. Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci USA 2000, 97:12840-12845. 10.1073/pnas.220410397, 18851, 11050161.
20. Brown AM, Deutch AY, Colbran RJ. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur J Neurosci 2005, 22:247-256. 10.1111/j.1460-9568.2005.04190.x, 16029214.
21. Fischer W, Franke H, Scheibler P, Allgaier C, Illes P. AMPA-induced Ca(2+) influx in cultured rat cortical nonpyramidal neurones: pharmacological characterization using fura-2 microfluorimetry. Eur J Pharmacol 2002, 438:53-62. 10.1016/S0014-2999(02)01296-7, 11906710.
22. Nishi A, Bibb JA, Matsuyama S, Hamada M, Higashi H, Nairn AC, Greengard P. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. J Neurochem 2002, 81:832-841. 10.1046/j.1471-4159.2002.00876.x, 12065642.
23. Chergui K, Svenningsson P, Greengard P. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc Natl Acad Sci USA 2004, 101:2191-2196. 10.1073/pnas.0308652100, 357074, 14769920.
24. Chen PC, Chen JC. Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats. Neuropsychopharmacology 2005, 30:538-549. 10.1038/sj.npp.1300604, 15536496.
25. Takahashi S, Ohshima T, Cho A, Sreenath T, Iadarola MJ, Pant HC, Kim Y, Nairn AC, Brady RO, Greengard P, Kulkarni AB. Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci USA 2005, 102:1737-1742. 10.1073/pnas.0409456102, 547862, 15665076.
26. Nishi A, Watanabe Y, Higashi H, Tanaka M, Nairn AC, Greengard P. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc Natl Acad Sci USA 2005, 102:1199-1204. 10.1073/pnas.0409138102, 545831, 15657149.
27. Sun JY, Wu XS, Wu LG. Single and multiple vesicle fusion induce different rates of endocytosis at a central synapse. Nature 2002, 417:555-559. 10.1038/417555a, 12037569.
28. Meinrenken CJ, Borst JG, Sakmann B. Local routes revisited: the space and time dependence of the Ca2+ signal for phasic transmitter release at the rat calyx of Held. J Physiol 2003, 547:665-689. 2342725, 12562955.
29. Fisone G, Hakansson K, Borgkvist A, Santini E. Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms. Physiol Behav 2007, 92:8-14. 10.1016/j.physbeh.2007.05.028, 17585965.
30. Greengard P. The neurobiology of slow synaptic transmission. Science 2001, 294:1024-1030. 10.1126/science.294.5544.1024, 11691979.
31. Yan Z, Hsieh-Wilson L, Feng J, Tomizawa K, Allen PB, Fienberg AA, Nairn AC, Greengard P. Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin. Nat Neurosci 1999, 2:13-17. 10.1038/4516, 10195174.
32. Flores-Hernandez J, Hernandez S, Snyder GL, Yan Z, Fienberg AA, Moss SJ, Greengard P, Surmeier DJ. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J Neurophysiol 2000, 83:2996-3004.
33. Flores-Hernandez J, Cepeda C, Hernandez-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA, Greengard P, Levine MS. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. J Neurophysiol 2002, 88:3010-3020. 10.1152/jn.00361.2002, 12466426.
34. Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J Neurosci 2000, 20:8443-8451.
35. Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001, 2:695-703. 10.1038/35094560, 11584307.
36. Liu FC, Graybiel AM. Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron 1996, 17:1133-1144. 10.1016/S0896-6273(00)80245-7, 8982161.
37. Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. J Neurochem 2000, 75:248-257. 10.1046/j.1471-4159.2000.0750248.x, 10854268.
38. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 2000, 405:955-959. 10.1038/35016089, 10879537.
39. Mangiavacchi S, Wolf ME. Stimulation of N-methyl-D-aspartate receptors, AMPA receptors or metabotropic glutamate receptors leads to rapid internalization of AMPA receptors in cultured nucleus accumbens neurons. Eur J Neurosci 2004, 20:649-657. 10.1111/j.1460-9568.2004.03511.x, 15255976.
40. Qi Z, Miller GW, Voit EO. Computational systems analysis of dopamine metabolism. PLoS ONE 2008, 3:e2444. 10.1371/journal.pone.0002444, 2435046, 18568086.
41. Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 2003, 6:501-506.
42. Langmead CJ, Watson J, Reavill C. Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 2008, 117:232-243. 10.1016/j.pharmthera.2007.09.009, 18082893.
43. Sato K, Ueda H, Okumura F, Misu Y. Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats. Neurosci Lett 1994, 173:59-62. 10.1016/0304-3940(94)90149-X, 7936424.
44. Phillips JM, Lam HA, Ackerson LC, Maidment NT. Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease. Eur J Neurosci 2006, 23:151-160. 10.1111/j.1460-9568.2005.04550.x, 16420425.
45. Lindskog M, Kim M, Wikstrom MA, Blackwell KT, Kotaleski JH. Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation. PLoS Comput Biol 2006, 2:e119. 10.1371/journal.pcbi.0020119, 1562452,1562452, 16965177.
46. Barbano PE, Spivak M, Flajolet M, Nairn AC, Greengard P, Greengard L. A mathematical tool for exploring the dynamics of biological networks. Proc Natl Acad Sci USA 2007, 104:19169-19174. 10.1073/pnas.0709955104, 2148263, 18032599.
47. Fernandez T, Schiappa R, Girault JA, Le Novère N. DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput Biol 2006, 2:e176. 10.1371/journal.pcbi.0020176, 1761654,1761654, 17194217.
48. Bhalla US, Iyengar R. Emergent properties of networks of biological signaling pathways. Science 1999, 283:381-387. 10.1126/science.283.5400.381, 9888852.
49. Usui H, Inoue R, Tanabe O, Nishito Y, Shimizu M, Hayashi H, Kagamiyama H, Takeda M. Activation of protein phosphatase 2A by cAMP-dependent protein kinase-catalyzed phosphorylation of the 74-kDa B" (delta) regulatory subunit in vitro and identification of the phosphorylation sites. FEBS Lett 1998, 430:312-316. 10.1016/S0014-5793(98)00684-X, 9688562.
50. Hemmings HC, Nairn AC, Greengard P. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1. J Biol Chem 1984, 259:14491-14497.
51. Girault JA, Hemmings HC, Williams KR, Nairn AC, Greengard P. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. J Biol Chem 1989, 264:21748-21759.
52. Hemmings HC, Greengard P. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J Neurosci 1986, 6:1469-1481.
53. Hofmann F, Bechtel PJ, Krebs EG. Concentrations of cyclic AMP-dependent protein kinase subunits in various tissues. J Biol Chem 1977, 252:1441-1447.
54. Nagase T, Murakami T, Nozaki H, Inoue R, Nishito Y, Tanabe O, Usui H, Takeda M. Tissue and subcellular distributions, and characterization of rat brain protein phosphatase 2A containing a 72-kDa delta/B" subunit. J Biochem 1997, 122:178-187.
55. Sim AT, Ratcliffe E, Mumby MC, Villa-Moruzzi E, Rostas JA. Differential activities of protein phosphatase types 1 and 2A in cytosolic and particulate fractions from rat forebrain. J Neurochem 1994, 62:1552-1559.
56. Ouimet CC, da Cruz e Silva EF, Greengard P. The alpha and gamma 1 isoforms of protein phosphatase 1 are highly and specifically concentrated in dendritic spines. Proc Natl Acad Sci USA 1995, 92:3396-3400. 10.1073/pnas.92.8.3396, 42173, 7724573.
57. Desdouits F, Cheetham JJ, Huang HB, Kwon YG, da Cruz e Silva EF, Denefle P, Ehrlich ME, Nairn AC, Greengard P, Girault JA. Mechanism of inhibition of protein phosphatase 1 by DARPP-32: studies with recombinant DARPP-32 and synthetic peptides. Biochem Biophys Res Commun 1995, 206:652-658. 10.1006/bbrc.1995.1092, 7826384.